India’s top vaccine maker to produce Sputnik V

A man holds his arm after receiving a Sputnik V coronavirus vaccine at a vaccination centre in Gostinny Dvor, a huge exhibition place in Moscow (Pavel Golovkin/AP)

Russia’s sovereign fund has announced a deal with a top Indian vaccine manufacturer to produce the Russia-designed Sputnik V vaccine.

The Russian Direct Investment Fund, or RDIF, said its deal with the Serum Institute of India, the world’s largest vaccine manufacturer by volume, envisions annual production of more than 300 million doses of the vaccine starting in September.